Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield(TM)®) and BBV-152 (Covaxin(TM)®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study

BACKGROUND: We assessed the humoral immune response of both ChAdOx1-nCOV (Covishield(TM)) and BBV-152 (Covaxin(TM)) vaccines in Indian health care workers (HCW). METHODS: A Pan-India, Cross-sectional, Coronavirus Vaccine-induced Antibody Titre (COVAT) study was conducted that measured SARS-CoV-2 ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Awadhesh Kumar, Phatak, Sanjeev Ratnakar, Singh, Ritu, Bhattacharjee, Kingshuk, Singh, Nagendra Kumar, Gupta, Arvind, Sharma, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461292/
https://www.ncbi.nlm.nih.gov/pubmed/34600747
http://dx.doi.org/10.1016/j.vaccine.2021.09.055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461292/
https://www.ncbi.nlm.nih.gov/pubmed/34600747
http://dx.doi.org/10.1016/j.vaccine.2021.09.055

Ejemplares similares